Clene Inc. Stock News

Which penny stocks are you watching right now? The post Hot Penny Stocks to Watch Today? 3 For Your List in July  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. The Dow traded down 1.5% to 30,307.00 while the NASDAQ fell 1.22% to 11,110.69. The S&P also f

Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume. Biomerica, Inc. (NASDAQ: BMRA) gained 23.6% to $3.6599 following news the company's breast self exam will now be

U.S. stocks traded lower this morning, following the release of economic reports on initial jobless claims and producer prices Following the market opening Thursday, the Dow traded down 1.92% to 30,18

Which penny stocks are you watching right now? The post Hot Penny Stocks to Watch Today?

Clene (CLNN) stock is heading higher on Thursday following the release of data from a long-term clinical trial of CNM-Au8. The post Why Is Clene (CLNN) Stock Soaring 23% Today?

SALT LAKE CITY, July 14, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage bioph

Clene Inc (NASDAQ: CLNN) reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8 compared to initially randomized placebo-treated par

Pliant Therapeutics, Inc. (PLRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further str

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) gained 82.4% to $0.9819 after the company anno

SALT LAKE CITY, June 27, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biophar

ALS Drug Developer Clene to Broadcast Message of Support with Former Yankees Outfielder Chris Dickerson on Nasdaq MarketSite Tower in Times Square ALS Drug Developer Clene to Broadcast Message of Supp

$3 million 60-month loan to support capital equipment purchases in new 75,000-square-foot facility in Elkton, Maryland, for manufacture of Clene’s lead drug candidate, CNM-Au8®, for treatment of AL

Clene Inc. (CLNN) delivered earnings and revenue surprises of -16.67% and 76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?